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a b s t r a c t
S-Adenosylmethionine (SAM) serves as a methyl donor in biological transmethylation reactions. S-
Adenosylhomocysteine (SAH) is the product as well as the inhibitor of transmethylations and the ratio
SAM/SAH is regarded as the measure of methylating capacity (“methylation index”). We present a rapid
and sensitive LC–MS/MS method for SAM and SAH determination in mice tissues. The method is based
on chromatographic separation on a Hypercarb column (30 mm × 2.1 mm, 3m particle size) ﬁlled with
porous graphitic carbon stationary phase. Sufﬁcient retention of SAM and SAH on the chromatographic
packing allows simple sample preparation protocol avoiding solid phase extraction step. No signiﬁcantass spectrometry
iquid chromatography
ouse tissues
matrix effects were observed by analysing the tissue extracts on LC–MS/MS. The intra-assay precision was
less than 9%, the inter-assay precision was less than 13% and the accuracy was in the range 98–105% for
both compounds. Stability of both metabolites during sample preparation and storage of tissue samples
was studied: the SAM/SAH ratio in liver samples dropped by 34% and 48% after incubation of the tissues
at 4 ◦C for 5 min and at 25 ◦C for 2 min, respectively. Storage of liver tissues at −80 ◦C for 2 months resulted
ratio
M anin decrease of SAM/SAH
obtaining valid data of SA
. Introduction
S-Adenosylmethionine (SAM) and S-Adenosylhomocysteine
SAH) are metabolites involved in the conversion of methion-
ne to homocysteine in the proximal part of the methionine
ycle. S-Adenosylmethionine is synthesized from methionine and
TP in a reaction catalysed by methionine adenosyltransferase.
AM is providing methyl group moieties in several dozens of
ransmethylation reactions of crucial biological importance [1]. S-
denosylhomocysteine, produced by the methyl group transfer, has
een demonstrated to inhibit at various concentrations these reac-
ions [1–4]. It has been proposed, that transmethylation reactions
ay be inhibited also by low ratio between SAM and SAH [1,5–7],
ometimes regarded in literature as the “methylation index”. The
AH concentration and SAM/SAH ratio may be altered in various
linical conditions as a result of accumulation of homocysteine,
hich reacts with adenosine and forms SAH by the reverse action
f the enzyme S-adenosylhomocysteine hydrolase.
During the past decade, animal models of several disorders
f homocysteine metabolism became available for studying the
athogenesis of the respective enzyme deﬁciencies [8–11]. In
ontrast to human patients the animal models offer a unique oppor-
∗ Corresponding author. Fax: +420 224 967 081.
E-mail address: jkrijt@LF1.cuni.cz (J. Krijt).
570-0232 © 2009 Elsevier B.V. Open access under CC BY license.
oi:10.1016/j.jchromb.2009.05.039by 40%. These results demonstrate that preanalytical steps are critical for
d SAH in tissues.
© 2009 Elsevier B.V. Open access under CC BY license.
tunity to determine concentration of relevant metabolites including
SAM and SAH also in tissues, which may help further elucidating
the pathogenetic mechanisms in homocystinurias. The aim of this
study was to develop an assay to monitor the levels of SAM and SAH
in animal tissue samples and to explore the preanalytical conditions
for this assay.
Various methods for the analysis of SAM and SAH have been
published. These include LC methods with UV detection utilizing
ion-pairing [12–17] or cation exchange chromatography [12,18],
LC methods with ﬂuorescence detection after conversion of the
analytes to ﬂuorescent analogs [5,19–21], LC methods with elec-
trochemical detection [22] and capillary electrophoresis method
[23]. More recently described sensitive LC–MS [24] and LC–MS/MS
methods [25,26] enable quantiﬁcation of SAM and SAH presented
in plasma or cerebrospinal ﬂuid in low nanomolar concentration,
but require a SPE extraction step and sample volumes ranging from
250L to 1 mL. Because the polar SAM and SAH are just weakly
retained on C18 columns without the use of ion-pairing additive
in the mobile phase, SPE is primarily required in the LC–MS/MS
applications to separate both analytes from salts and other early
eluting matrix components that can lead to ion-suppression on
mass spectrometer.
Other authors used penta-ﬂuorinated column for LC–MS/MS
analysis of SAM and SAH in mouse embryos [27]. Increased reten-
tion of SAM and SAH on this column, accomplished by the use of
ion-pairing reagent – heptaﬂuorobutyric acid – in the mobile phase,
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50M of [2H3]-SAM and 75M of [13C5]-SAH. Before analysis, the062 J. Krijt et al. / J. Chromat
nables to simplify the sample preparation to tissue homogeniza-
ion and heat precipitation of proteins. The limits of detection of
he latter three LC–MS/MS methods are in the range of 2–10 and
–2.5 nmol/L for SAM and SAH, respectively.
Our goal was to develop a sensitive LC–MS/MS method with
inimal sample requirements and with sufﬁcient sample through-
ut. Preferably, we tried to omit the SPE step, which demands
sually higher sample and reagents volumes, prolongs labour time
nd increases the cost of the method. This was accomplished by
he use of column ﬁlled with porous graphitic carbon (PGC) as a
tationary phase, which retains both analytes and separates them
rom interfering compounds causing ion-suppression effects on
ass spectrometer. In contrast to Burren et al. [27], no ion-pairing
dditives to the mobile phase were required to achieve sufﬁcient
etention of SAM and SAH on the column sorbent.
The methods for metabolite determinations in biological sam-
les should be validated in detail focusing on stability of the
etabolites in the sample matrix. A marked decrease of SAM and
ncrease of SAH has been demonstrated in untreated plasma sam-
les stored for 3 h at room temperature and for 1 month at −20 ◦C
26]. The acidiﬁcation of the plasma with acetic acid to pH 4.5–5.0
tabilized both SAM and SAH in the samples for at least 4 months.
n tissues, the metabolite changes may occur within seconds due to
schemic conditions during collection of tissue samples [15]. Rapid
ostmortem increase of SAM and SAH in mice tissues have been
eported also by Helland and Ueland [28]. Therefore we tested the
tability of SAM and SAH in excised tissues by incubating them at 4
nd 25 ◦C for different time intervals.
If we have to use some cliché to describe the presented method,
e would choose the attributes simple, cost effective and repro-
ucible. This paper includes detailed sample preparation protocol
ith regard to demonstrated instability of SAM and SAH in tissue
amples, and presents an original chromatographic separation of
AM and SAH utilizing simple mobile phases without ion-pairing
eagents.
. Material and methods
.1. Chemicals
Acetonitrile (LC ultra-gradient grade) was purchased from
.T.Baker (Deventer, Netherlands). The internal standard [2H3]-SAM
as purchased from CDN Isotopes (Pointe-Claire, Quebec, Canada),
13C5]-SAH was obtained from Dr. Herman J. ten Brink (VU Medical
enter, Amsterdam, Netherlands). SAM p-toluenesulfonate salt for
reparation of SAM standards as well as all other chemicals was
btained from Sigma–Aldrich (Prague, Czech Republic).
.2. Apparatus and conditions
The LC–MS/MS system consisted of the Agilent 1100 Series LC
ystem (Agilent Technologies, Palo Alto, CA, USA) coupled with API
200 triple quadrupole mass spectrometer with electron ion source
nd operated with Analyst software, Vision 1.4 (Applied Biosystems,
oster City, CA, USA).
The separation was performed on a Hypercarb column
30 mm × 2.1 mm, 3m particle size, Thermo Fisher Scientiﬁc, Inc.,
SA) ﬁlled with porous graphitic carbon stationary phase. Gradi-
nt elution was composed of 0.1% formic acid in water (eluent A)
nd 0.1% formic acid in acetonitrile (eluent B). Gradient started with
00% A, followed by an increase to 32% B in 6 min. The column was
han ﬂushed with 80% B for 2 min and regenerated with 100% A
or another 7 min. The ﬂow rate was 0.3 mL/min. The eluent was
iverted to waste at the beginning and end of each chromatographic
un to prevent source contamination by salts and other compounds.877 (2009) 2061–2066
Between the 5th and 10th min, the eluent was switched to the ion
source of the mass spectrometer.
The detection of the analytes was carried out using pos-
itive electrospray ionization technique and selected reaction
monitoring mode. The precursor → product transitions for SAM
(m/z 399.3 → 250.3), SAH (m/z 385.3 → 136.3), [2H3]-SAM (m/z
402.3 → 250.3) and [13C5]-SAH (m/z 390.3 → 136.3) were moni-
tored. The scan dwell time was set at 0.3 s for both the analytes
and the internal standards. The optimized ion source parameters
were: declustering potential: 42 and 40 V for SAM and SAH, respec-
tively, collision energy: 25 and 27 V for SAM and SAH, respectively,
entrance potential: 4.5 V, collision cell exit potential: 5.2 and 5.8 V
for SAM and SAH, respectively, ionspray voltage: 4500 V and ion-
spray source temperature: 450 ◦C. The interface heater was set to
100 ◦C. The collision gas, curtain gas and ion source gas 1 and 2 (neb-
ulizer gas and turbo gas) were set to 5, 14, 60 and 60 psi, respectively.
2.3. Standards and calibration curves
Stock solutions of SAM and SAH were prepared by dissolv-
ing approximately 4 mg of each compound in 1000l of ice cold
water. The concentration of SAM and SAH in stock solution was
determined by UV absorption spectroscopy at 260 nm using molar
extinction coefﬁcient of 15400 [29]. The calibration samples in the
concentration range 1.25–320M were prepared by serial dilutions
of the stock solution with 0.4 M perchloric acid (PCA), the individ-
ual calibration points were 1.25, 5, 10, 20, 40, 80, 160 and 320M.
The calibration samples were aliquoted and stored at −80 ◦C.
The calibration curve was obtained by weighted linear regression
(weighing factor 1/x), the peak area ratio (analyte/internal stan-
dard) was plotted versus the analyte concentration.
2.4. Animals and tissue samples
Male C57BL/6J mice, aged 3–4 months, were used for determi-
nation of SAM and SAH in tissues and for experiments described
in the section “Method validation”. Mice were maintained in
a temperature- and light-controlled environment, they had free
access to tap water and standard laboratory food. The experiments
were approved by the Animal Care Committee of the 1st Fac-
ulty of Medicine. For the precision evaluation of the LC–MS/MS
determination in samples with high SAM and SAH concentrations
we used extracts from livers of cystathionine-ß-synthase deﬁcient
mice (C57BL/6J Cbs−/−) kindly provided by Dr. Jan P. Kraus, Univer-
sity of Colorado School of Medicine, USA.
2.5. Sample preparation
Mice were euthanized by decapitation, livers and kidneys were
quickly excised and immediately immersed in liquid nitrogen. The
snap frozen tissue samples were divided into pieces of approx-
imately 50–150 mg. Frozen tissue aliquots were handled with
utensils precooled in liquid nitrogen to prevent thawing of sam-
ples. Grinding of the frozen tissues to ﬁne powder was performed
in a precooled custom-made stainless steel pulverizer. Pulverized
tissues were homogenized and deproteinized at once in ice-cold
0.4 M PCA (600L of PCA/100 mg of tissue). The homogenate was
centrifuged 10 min at 7 000 × g at 10 ◦C and 30L of the supernatant
was mixed with 10L of internal standard solution containingsample was adjusted to pH 5–7 with 2.5 M K3PO4, left at 4 ◦C for
15 min to complete precipitation of potassium perchlorate and 5L
of clear supernatant was injected on the LC column. If not analyzed
immediately, the extracts were stored at −80 ◦C. The calibration
samples were processed identically as the tissue sample extracts.
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. Results and discussion
.1. Sample preparation
Protein precipitation is the simplest way of sample preparation
or LC–MS/MS analysis. There are pros and cons which should be
onsidered when choosing this approach instead of some of the
ther extraction methods. The pros are speed, reduction of sample
nd standard volumes to minimum resulting thus in cost effec-
iveness. The major disadvantage is the complexity of the sample
atrix which may lead to ion suppression effects and to possible
oss of sensitivity. We have chosen this option of sample prepara-
ion especially because of the minimal sample requirement. Using
ur sample preparation protocol, we obtained 300–900L of tis-
ue extract. Only a small aliquot (30L) of the extract was spiked
ith labeled internal standards in order to minimize the consump-
ion of the internal standard [13C5]-SAH which is expensive and
ommercially not readily available. The residual tissue extract can
e used for determination of additional metabolites, as described
reviously [30].
Because of instability of SAM and SAH in tissues we performed all
andlings with tissue specimens following the excision (including
artitioning, weighing, grinding) in liquid nitrogen frozen samples.
issue powderizing is required to prevent the formation of rubbery
ugget in Potter-Elvehjem homogenizer. The homogenization was
erformed in denaturing ice-cold perchloric acid solution, in order
o prevent enzymatic conversions of SAM and SAH during homoge-
ization and further procedures. Moreover, acidic pH of perchloric
cid stabilizes SAM, as previously reported [26].
.2. Chromatography
S-Adenosylmethionine is a polar compound and as such it is
oorly retained on standard reversed-phase columns. High water
ontent in the mobile phase and the presence of interfering sub-
tances close to the hold-up time (t0) result in poor ionization
fﬁciency in the mass spectrometric detection. Some authors use
on-pairing additives in the mobile phase to improve the reten-
ion and also to increase the content of organic solvent in the
obile phase, however, these additives may cause loss of sensitiv-
ty on mass spectrometer [31]. We aimed at developing a simple
C method for separation of SAM and SAH without the use of
on-pairing reagents in the mobile phase. From the several tested
olumns we selected a column packed with porous graphitic car-
on, which is a strong adsorbent offering retention mechanisms
ifferent from C18 stationary phases [32]. SAM was retained on
he PGC column washed with 0.1% formic acid and was eluted by
ncreasing the concentration of acetonitrile in the mobile phase.
t 20% acetonitrile the retention of SAM dropped below 1 min,
hich we regarded as insufﬁcient retention considering possible
onization suppression by compounds eluting at the t0. Because the
etention factor of SAH was too high (more than 15 min) at acetoni-
rile concentrations lower than 20% in the mobile phase, we ﬁnally
dopted a gradient elution to keep the retention of both metabolites
n optimal range. After optimization of chromatographic condi-
ions, the retention times of SAM and SAH were 5.9 and 7.8 min,
espectively. The total chromatographic run time including column
egeneration was 15 min. Typical chromatogram of mouse liver
xtract is shown in Fig. 1.
.3. Method validation.3.1. Linearity and limit of detection
The calibration curves were linear in the range 1.25–320M
or both SAM and SAH. The calibration curve equation is
= bx + c, where y represents analyte/internal standard peak877 (2009) 2061–2066 2063
area ratio and x represents concentration of the analyte in
M. The mean equation (curve coefﬁcients ± standard devia-
tion) of the calibration curve (n = 5) was y = 0.0643(±0.0018)x +
0.0025(±0.0018) (correlation coefﬁcient r = 0.999) for SAM and
y = 0.0434(±0.0009)x − 0.0088(±0.0043) (correlation coefﬁcient
r = 0.999) for SAH.
The limit of detection (at a signal-to-noise ratio of 5:1) deter-
mined in standards diluted in 0.4 M PCA was 7.5 nM for SAM and
15 nM for SAH.
3.3.2. Matrix-effects
Simplicity of the sample preparation protocol, which consists of
protein deproteination and sample neutralization without the SPE
step, brings in return the risk of increased matrix effects. We have
evaluated the ion suppression effects by two methods.
Firstly, we compared the MRM signals in deproteinized tissue
sample spiked with known SAM and SAH concentration (50M)
to that of the analyte standards prepared in water. The compar-
ison was done after subtracting the signals of endogenous SAM
and SAH from the signals obtained in spiked sample. The results
expressed as a mean(±standard deviation) of data obtained by
replicate set of analyses (n = 5) showed enhancement of the SAM
signal in spiked tissue extracts versus standards prepared in water
by 9%(±4), whereas spiking of the tissue extracts with SAH resulted
in small ionization suppression by 4%(±2). If analyte/I.S. ratios were
used for the calculations as described above, the mean differences
between data obtained from analysis of spiked tissue extracts and
standard samples were lower than 2% for both analytes, showing
that the matrix effects affecting the analyte signal were com-
pensated by analogous enhancement or suppression of respective
internal standards.
Secondly, we infused continuously a 100M standard solution
of SAM and SAH by means of a syringe pump connected to the col-
umn efﬂuent into the MS interface and injected the tissue sample
into the LC system. The drop in the constant baseline signal would
have indicated the ion suppression phenomenon [33]. This method
gives information about the time intervals after sample injection, in
which the ion suppression is manifested, and to what extent. Our
results showed that the drop in signal in the ﬁrst 2 min of analy-
sis was more than 50%. At 4.5 min after sample injection, i.e. more
than 1 min before the tR of SAM and SAH, the signal practically
returned to the initial level and remained unsuppressed until the
end of analysis (Fig. 2).
3.3.3. Precision and accuracy
We evaluated (a) the precision of the entire method, includ-
ing sample preparation and LC–MS/MS determination and (b) the
precision of the LC–MS/MS determination alone. The reason for
this approach was to test whether the complex sample prepa-
ration protocol added signiﬁcant imprecision to the LC–MS/MS
determination alone. Because of ethical reasons, we performed
the precision determination with limited number of liver samples
excised from male C57BL/6J mice (see Section 2.4.). For the intra-day
precision determination of the entire method we analyzed three
pieces of liver tissue in one day and for inter-day precision we ana-
lyzed the fresh liver sample and aliquotes stored at −80 ◦C for 3 and
10 days.
To evaluate the precision of the LC–MS/MS method alone we
used pooled tissue extracts with normal and high concentrations
of SAM and SAH. The extract with normal SAM and SAH levels
was obtained from liver of male C57BL/6J mice, the extract with
high SAM and SAH levels was obtained from liver of cystathionine-
ß-synthase deﬁcient mice (see Section 2.4). The extracts were
analyzed six times in the same analytical run (intra-day, LC–MS/MS)
and on six separate runs within 6 weeks (inter-day, LC–MS/MS).
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Fig. 1. Chromatograms of SAM and SAH in mouse liver. The panels show selected reaction monitoring of the transitions m/z 399.3 → 250.3 for SAM (a); 402.3 → 250.3 for
[2H3]-SAM (b); 385.3 → 136.3 for SAH (c) and 390.3 → 136.3 for [13C5]-SAH (d).
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aig. 2. Infusion chromatograms showing the ion suppression effect. The column efﬂ
o the mass spectrometer interface. 5L of liver extract was injected onto the LC–
85.3 → 136.3 for SAH (b) was monitored.The results are given in Tables 1 and 2. The data show very
ood intra- and inter-day precision of the LC–MS/MS determination
lone, the RSD did not exceed 5%. These results show very good sta-
ility of the tissue extracts stored at −80 ◦C for at least 6 weeks. Sat-
able 1
ntra-assay precision.
N nmol/g wet weight RSD (%)
SAM SAH SAM SAH
ntire method 4 60.6 27.2 8.8 7.8
C–MS/MSa 6 38.9 65.4 3.9 2.2
C–MS/MSb 6 251.4 998.5 4.5 1.2
he determinations for intra-assay precision studies were performed in liver tissue
rom C57BL/6J mouse (entire method) and liver extracts from C57BL/6J (LC–MS/MSa)
nd C57BL/6J Cbs−/− (LC–MS/MSb) mice.as mixed with 200M standard solution of SAM and SAH, continuously introduced
S system. The drop in signal of the transition m/z 399.3 → 250.3 for SAM (a) andisfactory performance below 9% was also obtained for the intra-day
precision of the entire method, showing that the sample prepa-
ration protocol is reproducible and does not add a signiﬁcant
imprecision. The higher values of RSD calculated for inter-day preci-
Table 2
Inter-assay precision.
N nmol/g wet weight RSD (%)
SAM SAH SAM SAH
Entire method 4 53.8 35.4 10.6 12.7
LC–MS/MSa 6 40.7 61.1 4 4.5
LC–MS/MSb 6 263.5 937.7 5.8 4.1
The determinations for inter-assay precision studies were performed in liver tissue
from C57BL/6J mouse (entire method) and liver extracts from C57BL/6J (LC–MS/MSa)
and C57BL/6J Cbs−/− (LC–MS/MSb) mice.
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Table 3
Accuracy data for the LC–MS/MS determination in liver extracts.
N SAM Accuracy (%) SAH Accuracy (%)
Added (M) Mean ± SD measured (M) Added (M) Mean ± SD measured (M)
5 0 7.1 ± 0.2 0 10.4 ± 0.2
5
5
T L/6J m
s
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F
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K
F
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F
5
110 16.9 ± 0.3 98.4
80 91 ± 0.8 104.9
he determinations for accuracy studies were performed in liver extract from C57B
ion for SAH determination (12.7%) may be explained by instability
f SAH during storage of tissue samples at −80 ◦C for 10 days (see
ection 3.3.4.2).
Accuracy was determined by spiking liver homogenate obtained
rom C57BL/6J mice with known concentrations of SAM and
AH. The concentrations of SAM and SAH in each spiked liver
omogenate were determined by ﬁve replicate measurements. The
etermined concentration in the spiked samples was expressed as
percentage of the predicted concencentration, which was calcu-
ated as a sum of the added concentration and the endogenous
evel of the analyte in the unspiked sample. The results are given in
able 3. The calculated accuracy for both analytes was in the range
f 98.4–104.9%.
.3.4. Sample stability
Sample stability studies were performed with tissues excised
mmediately from the sacriﬁced mice and incubated at either 25, 4
r −80 ◦C, respectively.
.3.4.1. Short-term stability of tissues at 25 and 4 ◦C. The time
ntervals, during which the tissues may have been exposed to
on-freezing temperatures in the course of excision, weighing
r homogenization, were not always speciﬁed in the previously
ublished methodological studies. The stability study should
emonstrate how the metabolite concentrations do change dur-ng these procedures and how meticulous the sample preparation
rotocol should be. In this study, liver and kidney tissues were
ncubated after excision from the mice at room temperature
25 ◦C) for 2 and 5 min and at 4 ◦C for 5 and 15 min, respec-
ively.
able 4
tability of SAM and SAH in mice tissues incubated at −80, 4 ◦C and 25 ◦C.
iver
nmol/g wet weight
SAM SAH SAM
resh liver 58.4 29.8 2.0
min at 25 ◦C 48.5 47.7 1.0
min at 25 ◦C 46.6 64.7 0.7
resh liver 60.6 27.2 2.2
min at 4 ◦C 64.2 43.2 1.5
5 min at 4 ◦C 58.9 47.8 1.2
resh liver 60.3 40.7 1.5
months at −80 ◦C 58.7 65.9 0.9
months at −80 ◦C 48.5 68.1 0.7
idney
nmol/g wet weight
SAM SAH SAM/SA
resh kidney 30.7 6.6 4.6
min at 25 ◦C 31.9 8.6 3.7
min at 25 ◦C 30.4 14.1 2.2
resh kidney 33.7 6.5 5.2
min at 4 ◦C 29.2 7.8 3.7
5 min at 4 ◦C 29.6 8.9 3.312.5 22.7 ± 0.4 98.9
100 114.3 ± 5 103.9
ouse spiked with known concentrations of SAM and SAH.
The results are shown in Table 4. After incubation of liver tis-
sues for just 2 min at 25 ◦C, there was a 17% decrease of SAM
accompanied by a 60% increase in SAH concentration, resulting in
a 48.1% decrease in the SAM/SAH ratio. These changes were even
more evident after 5 min incubation, after which the SAM/SAH ratio
decreased by 63.2%. Similar situation was observed during incuba-
tion at 4 ◦C – the SAM/SAH ratio dropped by 33.8% and 44.9% after
incubation for 5 and 15 min, respectively. As shown in Table 4, anal-
ogous changes were observed also by incubating kidney samples at
25 and 4 ◦C. These results show high instability of SAM and espe-
cially of SAH in tissue samples at both 25 and 4 ◦C, demonstrating
the need for specialized sample preparation protocol to prevent the
metabolite conversions.
3.3.4.2. Long-term stability of tissues stored at −80 ◦C. To evaluate
the changes of SAM, SAH and SAM/SAH ratio during storage of
tissues at −80 ◦C we analyzed tissue aliquots stored for 2 and 6
months, respectively. The results given in Table 4 show changes
analogous to incubation of tissues at 25 and 4 ◦C: decrease of SAM,
increase of SAH and resulting decrease of SAM/SAH ratio for 39.8
and 51.9% after 2 and 6 months, respectively.
3.4. Mice tissue concentrations of SAM and SAH.
The concentrations of SAM and SAH in mice tissues excised
from male C57BL/6J mice, aged 3–4 months (see Section 2.4.) are
shown in Table 5. The values are in agreement with data pub-
lished in two papers [16,23], although other groups have found
approximately twofold higher SAM levels in liver and kidney tis-
sues compared to us [14,34]. Helland and Ueland [28] found 2 to 3
Difference (%)
/SAH SAM SAH SAM/SAH
−17.0 60.0 −48.1
−20.2 116.8 −63.2
6.0 59.1 −33.8
−2.8 75.9 −44.9
−2.6 61.8 −39.8
−19.5 67.3 −51.9
Difference (%)
H SAM SAH SAM/SAH
4.1 30.0 −19.9
−0.9 113.2 −53.5
−13.2 19.4 −27.7
−12.1 36.8 −36.1
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Table 5
SAM and SAH levels in mice tissues (male C57BL/6J, aged 3–4 months).
N nmol/g wet weight SD nmol/g wet weight SD
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[
1048.
[31] S.A. Gustavsson, J. Samskog, K.E. Markides, B. Langstrom, J. Chromatogr. A 937SAM SAH
iver 4 58.3 3.2 33.3 6.1
idney 4 33.7 3.1 6.9 0.5
imes lower concentrations of SAH in liver and kidney, i.e. 13 nmol/g
et weight and 1.9 nmol/g wet weight, respectively. These authors,
owever, used special protocol for isolation of “in situ” freezed
issues from anesthetized animals submerged in liquid nitrogen.
imilarly, Delabar et al. reported lower SAH concentration in kidney,
.e. below 1 nmol/g wet weight, using “freeze-clamp-technique” for
issue collection [15]. This protocol prevents ischemia, which may
esult in increases of determined adenine nucleosides concentra-
ions, including SAM and SAH. The latter two protocols of tissue
solation are not approved in our laboratory and could not have
een adopted.
.5. Method application
Presented method was used to determine tissue concentra-
ions in mice tissues. The concentrations of SAM and SAH in tissue
omogenates was in micromolar range whereas the limit of detec-
ion of our method is at least two magnitudes lower. The sensitivity
f our method enables determination of SAM and SAH in whole
lood extracts prepared by deproteinization of whole blood with
qual volume of 0.6 M PCA, which was proved in pilot experiments.
he whole blood concentrations of SAM and SAH are in the range
f hundreds of micromoles, which is close to the detection limits
f some published LC-UV methods, but still easily detectable using
ur LC–MS/MS method. The concentrations of SAH in plasma are,
owever several dozens of nanomoles and are too low to be deter-
ined using our method without further optimalization. Lowering
he detection limit may be possible for example by the use of one
f the variety of SPE methods, as described for example in previous
ublication [24].
. Conclusions
The presented method allows precise and sensitive determi-
ation of SAM and SAH. Limits of detection of presented method
7.5 nM for SAM and 15 nM for SAH – are at least one order of mag-
itude lower than in previously described LC-UV methods used
or determination of SAM and SAH and are comparable with the
ensitivity of published LC–MS/MS methods.
The method comprises special sample preparation protocol to
revent metabolite changes due to demonstrated limited stability
f the analytes in tissue samples. The stability studies show that tis-
ues samples should be snap frozen in liquid nitrogen immediately
fter excision, kept frozen at −80 ◦C and processed by the described
rotocol as soon as possible, preferably within a week.cknowledgements
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